Pulmonary Hypertensive Vascular Disease: Pathobiology & Treatment
Learning Objectives
Re‑conceptualize pediatric pulmonary hypertension as pulmonary hypertensive vascular disease
Explain why adult hemodynamic definitions are insufficient for children
Describe pediatric‑specific classification systems for pulmonary vascular disease
Apply a multidisciplinary framework to the management of pediatric PH
Implement a physiology‑based, stepwise approach to pulmonary hypertensive crisis in the ICU
Author(s)
Jeffrey Fineman, MD
Chief, Pediatric Critical Care Specialist, Pediatric Critical Care | University of San Francisco School of Medicine
Associate investigator | University of San Francisco Cardiovascular Research Institute
Aleksandra E. Olszewski, MD
Physician, Assistant Professor of Critical Care Medicine and Pediatrics, Department of Critical Care Medicine | UPMC Children's Hospital of Pittsburgh
Traci Wolbrink, MD, MPH
Co-Director, OPENPediatrics; Co-Director, Center for Educational Excellence and Innovation; Program Director, Pediatric Critical Care Medicine Fellowship; Senior Associate in Critical Care Medicine | Boston Children’s Hospital
Associate Professor of Anaesthesia | Harvard Medical School
Jefferey Burns, MD, MPH
Assoc. Chief Medical Officer, Critical Care Services; Shapiro Chair in Critical Care Medicine, Division of Critical Care MedicineDirector, OPENPediatrics; Sr. Assoc. in Critical Care Medicine; Department of Anesthesiology, Critical Care & Pain Medicine | Boston Children's Hospital
Professor of Anesthesia | Harvard Medical School
Citation
Fineman J, Olszewski AE, Wolbrink TA, Burns JP. Pulmonary Hypertensive Vascular Disease: Pathobiology & Treatment. 4/2015. Online Video. OPENPediatrics. https://learn.openpediatrics.org/learn/course/internal/view/elearning/3053/pulmonary-hypertensive-vascular-disease-pathobiology-treatment.